Coronavirus: Hong Kong panel recommends Pfizer-BioNTech vaccine for use, but seeks more information over Norway deaths

• Unanimous backing from experts will go before health secretary for final decision, paving way for mass inoculation drive from mid-February
• Panel chairman says Pfizer-BioNTech vaccine’s benefits outweigh risks, but adds it will request more information from Norway on deaths there